How much cash does Rein Therapeutics, Inc. Common Stock generate?

Rein Therapeutics, Inc. Common Stock (RNTX) generated -$16.6M in operating cash flow over the trailing twelve months.

Where does Rein Therapeutics, Inc. Common Stock's cash flow data come from?

Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rein Therapeutics, Inc. Common Stock RNTX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$50.21M+18.1%	-$49.87M+20.7%	-$58.89M-101%	-$59.15M-135%	-$61.27M-239%
Depreciation and amortization	——	——	——	——	——
Stock-based compensation	$2.12M+71.9%	$2.22M+99.1%	$2.1M+67.5%	$1.16M+19.1%	$1.23M+29.7%
Impairment charges	——	$28.7M-22.4%	$30.78M+10.9%	$32.85M+77.6%	$34.93M+278%
Change in accounts payable	——	——	——	——	——
Change in accrued liabilities	——	——	-$2.95M—	-$2.49M—	$2.45M—
Change in other assets	——	——	——	——	$176K+1,500%
Change in other liabilities	——	——	——	——	——
Change in deferred revenue	——	-$712K+54.2%	-$922.5K+20.8%	-$1.13M-45.8%	-$1.34M-246%
Debt issuance costs and discount amortization	——	——	——	——	——
Net cash from operating activities	-$16.61M+28.4%	-$19.36M+13.1%	-$20.95M+24.8%	-$21.22M+17.4%	-$23.2M-13.6%
Acquisitions, net of cash acquired	——	——	——	——	——
Proceeds from issuance of common stock	——	——	——	——	——
Net cash from financing activities	$13.67M-28.1%	$9.76M-46.6%	$7.35M-78.4%	$5.45M-84.0%	$19M—
Net increase (decrease) in cash	-$2.98M+35.7%	-$9.65M-116%	-$13.63M-344%	-$16.22M-265%	-$4.64M-187%
Amortization Of Debt Discount Premium	——	——	——	——	——
Goodwill and other intangible asset impairment charges	——	$28.7M-22.4%	$30.78M+10.9%	$32.85M+77.6%	$34.93M+278%
Accrued expenses and other liabilities	——	——	-$2.95M—	-$2.49M—	$2.45M—
Other long-term liabilities	——	——	——	——	——
Increase (Decrease) in Other Operating Assets	$239K+290%	$0+100%	$0+100%	$1.64M—	-$126K—
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	$176K+1,500%
Exchange Offer (Note 12)	——	$0—	——	——	——
Proceeds From Notes Payable	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rein Therapeutics, Inc. Common Stock generate?: Rein Therapeutics, Inc. Common Stock (RNTX) generated -$16.6M in operating cash flow over the trailing twelve months.
Where does Rein Therapeutics, Inc. Common Stock's cash flow data come from?: Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.